Key terms

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ABT news

Yesterday 9:30pm ET Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Elevance Health (ELV) Yesterday 7:40am ET 3 Best Stocks to Buy Now, 4/18/2024, According to Top Analysts Yesterday 6:00am ET Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), US Physical Therapy (USPH) Yesterday 5:58am ET Buy Rating Affirmed: Abbott Labs Outperforms with Strong Q1 Sales and Upward Earnings Revision Yesterday 5:56am ET Strong Q1 Performance and Growth Prospects Justify Buy Rating for Abbott Labs Apr 17 10:00am ET Abbott says performance of business continues to be ‘very strong’ Apr 17 9:58am ET ABT Earnings: Abbott Beats Expectations with Q1 Earnings Apr 17 9:41am ET Unusually active option classes on open April 17th Apr 17 9:16am ET Abbott says broad-based growth across portfolio in Q1 Apr 17 7:36am ET Abbott reports Q1 worldwide COVID-19 testing sales $204M vs. $730M last year Apr 17 7:34am ET Abbott reports Q1 worldwide Medical Devices sales up 14.2% on reported basis Apr 17 7:33am ET Abbott sees Q2 adjusted EPS $1.08-$1.12, consensus $1.12 Apr 17 7:32am ET Abbott revises FY24 adjusted EPS view to $4.55-$4.70 from $4.50-$4.70 Apr 17 7:30am ET Abbott reports Q1 adjusted EPS 98c, consensus 95c Apr 17 7:05am ET Options Volatility and Implied Earnings Moves Today, April 17, 2024 Apr 17 3:59am ET RBC Capital Remains a Buy on Abbott Labs (ABT) Apr 16 8:25pm ET Notable companies reporting before tomorrow’s open Apr 16 1:13pm ET Notable companies reporting before tomorrow’s open Apr 16 1:13pm ET Notable companies reporting before tomorrow’s open Apr 15 7:00am ET Options Volatility and Implied Earnings Moves This Week, April 15 – April 19, 2024 Apr 04 4:08am ET Buy Rating Reaffirmed for Abbott Labs Amid Strong Growth and New Product Launches Apr 03 5:50am ET Abbott price target raised to $128 from $126 at Citi Apr 02 7:05pm ET Buy Rating Affirmed for Abbott Labs Following TriClip’s Favorable FDA Approval and Market Outlook Apr 02 9:01am ET Abbott receives FDA approval for TriClip Apr 01 9:02am ET Abbott announces FDA clearance of i-STAT TBI cartridge Mar 26 4:47am ET Abbott Labs (ABT) Gets a Buy from Wells Fargo Mar 12 5:20am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT) Mar 11 3:49pm ET FDA reports Abbott recalls HeartMate Touch Communication System Mar 07 5:56am ET Abbott Labs (ABT) Gets a Buy from Wells Fargo Mar 06 9:03am ET Abbott announces new data from studies with GLP-1 medicines and Freestyle Libre Feb 29 6:50am ET Analysts Offer Insights on Healthcare Companies: Sensei Biotherapeutics (SNSE), Abbott Labs (ABT) and Personalis (PSNL)

ABT Financials

1-year income & revenue

Key terms

ABT Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ABT Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms